FDA Withdraws Notice on Priority Review Voucher for Rare Pediatric Disease Product

Summary

The FDA is withdrawing a notice from the Federal Register that incorrectly announced the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application, which was published on September 30, 2021.